JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB111042

Anti-DGKK 抗体

Anti-DGKK antibody

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Polyclonal DGKK antibody. Suitable for IHC-P, ICC/IF and reacts with Human, African green monkey samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human DGKK aa 1200 to C-terminus.

別名を表示する

Diacylglycerol kinase kappa, DAG kinase kappa, DGK-kappa, 142 kDa diacylglycerol kinase, Diglyceride kinase kappa, DGKK

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DGKK antibody (AB111042)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DGKK antibody (AB111042)

ab111042 at 1/50 dilution staining DGKK in paraffin-embedded Human brain tissue by Immunohistochemistry. The image on the right is treated with the synthesized peptide.

Immunocytochemistry/ Immunofluorescence - Anti-DGKK antibody (AB111042)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-DGKK antibody (AB111042)

ab111042 at 1/100 dilution staining DGKK in COS7 cells by Immunofluorescence. The image on the right is treated with the synthesized peptide.

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human, African green monkey

アプリケーション

IHC-P, ICC/IF

applications

免疫原

Synthetic Peptide within Human DGKK aa 1200 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q5KSL6

style
left-column

組合せ製品

Primary Antibodies

AB196032

Anti-DDX3 antibody [6G8-F4-E3]

Immunocytochemistry/ Immunofluorescence - Anti-DDX3 antibody [6G8-F4-E3] (AB196032)

  • 0
  • 0
Primary Antibodies

AB97628

Anti-GLRA2 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GLRA2 antibody (AB97628)

  • 0
  • 0
Primary Antibodies

AB230950

Anti-VISTA antibody [EPR21050]

KO Validated|RabMAb|Recombinant|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VISTA antibody [EPR21050] (AB230950)

  • 0
  • 0
Primary Antibodies

AB184467

Anti-SHCBP1 antibody [EPR18843]

RabMAb|Recombinant

Immunoprecipitation - Anti-SHCBP1 antibody [EPR18843] (AB184467)

  • 0
  • 0
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "African green monkey": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/500", "ICCIF-species-notes": "<p></p>" } } }
style
left-column
style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
精製に関する特記事項
ab111042 was affinity-purified from Rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
保管に関する情報
Stable for 12 months at -20°C
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The protein diacylglycerol kinase kappa (DGKK) plays a role in the phosphorylation of diacylglycerol to produce phosphatidic acid. This reaction is important in lipid signaling pathways. DGKK has a molecular mass of roughly 135 kDa. It is expressed in various tissues including the brain heart and placenta suggesting that it has functions in diverse physiological processes.
Biological function summary

DGKK functions in the regulation of lipid second messengers which are critical for cellular signaling. It is not known to be part of a specific protein complex but it interacts with other signaling molecules to modulate cellular responses. These interactions suggest DGKK has roles in signaling cascades that control a number of cellular mechanisms.

Pathways

DGKK participates in the glycerolipid metabolism pathway and the signaling events controlled by protein kinase C (PKC). These pathways involve intricate networks of interactions that influence broader cellular functions like cell growth differentiation and apoptosis. DGKK's relationship with PKC is important as both proteins coordinate to regulate the levels of diacylglycerol an important signaling lipid.

DGKK has been implicated in the development of X-linked chondrodysplasia punctata (CDPX2). This disorder which affects bone growth may arise due to disruptions in lipid signaling and metabolism. Additionally research suggests possible associations with neurological disorders though specific connections and mechanisms remain under investigation. Mahajan et al. studied the potential links between DGKK and these conditions providing insights into its roles.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed : 16210324, PubMed : 23949095). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (Probable).
See full target information DGKK
style
left-column

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in neuroscience 18:1348478 PubMed38449737

2024

EZH2 inhibition reactivates epigenetically silenced and normalizes molecular and electrophysiological abnormalities in fragile X syndrome neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Minggang Fang,Sara K Deibler,Pranathi Meda Krishnamurthy,Feng Wang,Paola Rodriguez,Shahid Banday,Ching-Man Virbasius,Miguel Sena-Esteves,Jonathan K Watts,Michael R Green

Viruses 15: PubMed36851534

2023

Obesity Induces an Impaired Placental Antiviral Immune Response in Pregnant Women Infected with Zika Virus.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Cláudia Calvielli Castelo Branco,Emily Araujo De Oliveira,Nátalli Zanete Pereira,Ricardo Wesley Alberca,Amaro Nunes Duarte-Neto,Luiz Fernando Ferraz Da Silva,Fernanda Guedes Luiz,Naiura Vieira Pereira,Mirian Nacagami Sotto,Naiara Naiana Dejani,Patrícia Helen Carvalho Rondó,Elyzabeth Avvad-Portari,Zilton Farias Meira De Vasconcelos,Alberto José da Silva Duarte,Tamiris Azamor,Maria Notomi Sato
View all publications
style
left-column
style
left-column
style
right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com